Together with Muscular Dystrophy Canada (MDC) we are pleased to invite you to a webinar on Newborn screening for Spinal muscular atrophy and Pompe disease. This webinar is primarily targeted at Canadian clinicians, academics, and trainees with an interest in neuromuscular disease. This is a clinical/academic webinar with support from Sanofi through a restricted educational sponsorship; there is no involvement or influence from industry on program content. NMD4C and MDC are providing organizational and technical support.

Chair:  

• Dr. Alex MacKenzie | Professor of Pediatrics, uOttawa | Pediatrician, CHEO | Senior Scientist, CHEO Research Institute

Speakers and Agenda: 

4 years of newborn screening for SMA in Ontario

• Dr. Kristin Kernohan | Molecular Geneticist, Newborn Screening Ontario, CHEO

A new understanding of Pompe disease in the era of NBS

• Dr. Priya Kishnani | Professor of Pediatrics and Molecular Genetics & Microbiology, Division Chief, Medical Genetics, Duke University Medical Center 

Learning Objectives:

• Understand what is detected and not detected for Spinal muscular atrophy (SMA) as part of newborn screening
• Summarize the Ontario experience in screening for SMA
• Recognize early features of LOPD identified by NBS
• How to comprehensively evaluate babies with LOPD identified via NBS

The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.